|
C20ORF177 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.439400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.191300E-04 |
| Normal-vs-Stage2 |
8.045400E-01 |
| Normal-vs-Stage3 |
8.533400E-01 |
| Normal-vs-Stage4 |
4.924000E-01 |
| Stage1-vs-Stage2 |
1.449020E-01 |
| Stage1-vs-Stage3 |
1.153960E-01 |
| Stage1-vs-Stage4 |
4.952400E-01 |
| Stage2-vs-Stage3 |
7.568800E-01 |
| Stage2-vs-Stage4 |
7.518800E-01 |
| Stage3-vs-Stage4 |
5.911800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.101810E-02 |
| Normal-vs-AfricanAmerican |
2.471500E-02 |
| Normal-vs-Asian |
5.582500E-02 |
| Caucasian-vs-AfricanAmerican |
6.381600E-01 |
| Caucasian-vs-Asian |
7.835400E-01 |
| AfricanAmerican-vs-Asian |
9.109400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.393130E-04 |
| Normal-vs-Female |
6.469400E-01 |
| Male-vs-Female |
5.775300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.259430E-01 |
| Normal-vs-Extreme_Weight |
3.40819999999908E-06 |
| Normal-vs-Obese |
3.646200E-01 |
| Normal-vs-Extreme_Obese |
1.332080E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.354600E-01 |
| Normal_Weight-vs-Obese |
4.270200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.490600E-01 |
| Extreme_Weight-vs-Obese |
8.360200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.578200E-01 |
| Obese-vs-Extreme_Obese |
1.292560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.417800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.848200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.622090E-04 |
| Normal-vs-Age(81-100Yrs) |
1.047920E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.770600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.868220E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.117900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.144070E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.181700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.007400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.48349999999453E-05 |
| Normal-VS-Type2 PRCC |
1.354790E-01 |
| Normal-VS-KIRP CIMP |
5.635000E-01 |
| Normal-VS-Unclassified PRCC |
2.703400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.210800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.444200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.741500E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.922400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.995900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.153800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.676000E-03 |
| Normal-vs-N1 |
2.759200E-01 |
| Normal-vs-N2 |
1.918180E-02 |
| N0-vs-N1 |
9.740500E-03 |
| N0-vs-N2 |
8.140400E-01 |
| N1-vs-N2 |
1.995760E-01 |
|
|
